β-blockers promote angiogenesis in the mouse aortic ring assay

Journal of Cardiovascular Pharmacology

Volumn 64, Issue 1, 2014, Pages 21-27

  Stati, Tonino ^a   Musumeci, Marco ^a   Maccari, Sonia ^a   Massimi, Alessia ^a   Corritore, Elisa ^a   Strimpakos, Georgios ^b   Pelosi, Elvira ^a   Catalano, Liviana ^c   Marano, Giuseppe ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

^c National Blood Center   (Italy)

Author keywords

angiogenesis; aortic ring assay; wound; blockers

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CATECHOLAMINE; COLLAGEN TYPE 1; CYCLIC AMP; FORSKOLIN; ISOPRENALINE; METOPROLOL TARTRATE; PROPRANOLOL; VASCULOTROPIN; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; ASSAY; C57BL 6 MOUSE; CONTROLLED STUDY; IN VITRO STUDY; MALE; MICROVASCULATURE; MOUSE; MOUSE AORTIC RING ASSAY; NONHUMAN; PRIORITY JOURNAL; VASCULAR RING; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; SIGNAL TRANSDUCTION; THORACIC AORTA;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904250778     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000085     Document Type: Article

References (28)

1. Ciccarelli M, Sorriento D, Cipolletta E, et al. Impaired neoangiogenesis in b2-adrenoceptor gene-deficient mice: Restoration by intravascular human b2-adrenoceptor gene transfer and role of NFkB and CREB transcription factors. Br J Pharmacol. 2011;162:712Y721
2. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649Y2651
3. Lavine JA, Sang Y, Wang S, et al. Attenuation of choroidal neovascularization by b(2)-adrenoreceptor antagonism. JAMA Ophthalmol. 2013; 131:376Y382
4. Ristori C, Filippi L, Dal Monte M, et al. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: Antiangiogenic effects of badrenoreceptor blockade. Invest Ophthalmol Vis Sci. 2011;52:155Y170
5. Martini D, Monte MD, Ristori C, et al. Antiangiogenic effects of b2-adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy. J Neurochem. 2011;119:1317Y1329
6. Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12:939Y944
7. Sorriento D, Santulli G, Del Giudice C, et al. Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension. 2012;60:129Y136
8. Steinle JJ, Cappocia FC Jr, Jiang Y. Beta-adrenergic receptor regulation of growth factor protein levels in human choroidal endothelial cells. Growth Factors. 2008;26:325Y330
9. Weil J, Benndorf R, Fredersdorf S, et al. Norepinephrine upregulates vascular endothelial growth factor in rat cardiac myocytes by a paracrine mechanism. Angiogenesis. 2003;6:303Y309
10. Fredriksson JM, Lindquist JM, Bronnikov GE, et al. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J Biol Chem. 2000;275: 13802Y13811
11. Lutgendorf SK, Cole S, Costanzo E, et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res. 2003;9:4514Y4521
12. Park SY, Kang JH, Jeong KJ, et al. Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1a proteindependent mechanism. Int J Cancer. 2011;128:2306Y2316
13. Dal Monte M, Martini D, Latina V, et al. Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2012;53:2181Y2192
14. Baum O, Da Silva-Azevedo L, Willerding G, et al. Endothelial NOS is main mediator for shear stress-dependent angiogenesis in skeletal muscle after prazosin administration. Am J Physiol Heart Circ Physiol. 2004; 287:H2300YH2308
15. dela Paz NG, Walshe TE, Leach LL, et al. Role of shear-stress-induced VEGF expression in endothelial cell survival. J Cell Sci. 2012;125:831Y 843
16. Li J, Post M, Volk R, et al. PR39, a peptide regulator of angiogenesis. Nat Med. 2000;6:49Y55
17. Rohrer DK, Chruscinski A, Schauble EH, et al. Cardiovascular and metabolic alterations in mice lacking both beta1-and beta2-adrenergic receptors. J Biol Chem. 1999;274:16701Y16708
18. Bernstein D, Fajardo G, Zhao M, et al. Differential cardioprotective/ cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol. 2005;289:H2441Y2449
19. Baker M, Robinson SD, Lechertier T, et al. Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc. 2011;22:89Y104
20. Bond RA, Ijzerman AP. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci. 2006;27:92Y96
21. Galandrin S, Bouvier M. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogenactivated protein kinase reveals the pluridimensionality of efficacy. Mol Pharmacol. 2006;70:1575Y1584
22. Wisler JW, DeWire SM, Whalen EJ, et al. A unique mechanism of betablocker action: Carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007;104:16657Y16662
23. Chen J, Joyal J, Hatton C, et al. Propranolol inhibition of beta-adrenergic receptor does not suppress pathologic neovascularization in oxygeninduced retinopathy. Invest Ophthalmol Vis Sci. 2012;53:2968Y2977
24. Steinle JJ, Smith PG. Role of adrenergic receptors in vascular remodelling of the rat choroid. Br J Pharmacol. 2002;136:730Y734
25. Pullar CE, Le Provost GS, O'Leary AP, et al. b2AR antagonists and b2AR gene deletion both promote skin wound repair processes. J Invest Dermatol. 2012;132:2076Y2084
26. Souza BR, Santos JS, Costa AM. Blockade of beta1-and beta2-adrenoceptors delays wound contraction and re-epithelialization in rats. Clin Exp Pharmacol Physiol. 2006;33:421Y430
27. Rengo G, Cannavo A, Liccardo D, et al. Vascular endothelial growth factor blockade prevents the beneficial effects of b-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure. Circ Heart Fail. 2013;6:1259Y1267
28. Nicosia RF, Ottinetti A. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in threedimensional cultures of rat aorta: A comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol. 1990;26:119Y128